China Medical System Holdings Limited - Laporan Laba Rugi (TTM)

China Medical System Holdings Limited
DE ˙ DB ˙ KYG211081248
€ 1.47 ↑0.04 (2.80%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi China Medical System Holdings Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 6,582 6,946 7,313 7,681 8,009 8,337 8,640 8,942 9,046 9,150 9,232 9,313 8,663 8,013 7,514 7,014 7,242 7,469 7,664 7,860
Change (%) 5.54 5.29 5.02 4.27 4.10 3.63 3.50 1.17 1.15 0.89 0.88 -6.98 -7.50 -6.23 -6.65 3.24 3.14 2.62 2.55
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,703 1,812 1,889 1,966 2,028 2,090 2,111 2,133 2,124 2,114 2,111 2,107 2,022 1,937 1,892 1,848 1,947 2,047 2,145 2,242
Change (%) 6.36 4.27 4.09 3.15 3.06 1.01 1.00 -0.43 -0.43 -0.18 -0.18 -4.03 -4.20 -2.31 -2.37 5.39 5.11 4.78 4.56
% of Revenue 25.88 26.08 25.83 25.60 25.33 25.07 24.44 23.85 23.48 23.11 22.87 22.63 23.34 24.18 25.19 26.34 26.89 27.40 27.98 28.53
Gross Operating Profit 4,878 5,134 5,424 5,715 5,981 6,247 6,528 6,809 6,923 7,036 7,121 7,206 6,641 6,076 5,621 5,167 5,294 5,422 5,520 5,618
Change (%) 5.25 5.65 5.35 4.66 4.45 4.50 4.31 1.66 1.64 1.21 1.19 -7.84 -8.51 -7.48 -8.09 2.47 2.41 1.80 1.77
% of Revenue 74.12 73.92 74.17 74.40 74.67 74.93 75.56 76.15 76.52 76.89 77.13 77.37 76.66 75.82 74.81 73.66 73.11 72.60 72.02 71.47
SG&A 2,198 2,304 2,444 2,583 2,782 2,981 3,159 3,336 3,347 3,358 3,408 3,457 3,313 3,168 3,220 3,272 3,357 3,442 3,488 3,535
Change (%) 4.83 6.04 5.70 7.71 7.16 5.96 5.62 0.32 0.32 1.48 1.46 -4.19 -4.37 1.65 1.62 2.59 2.52 1.36 1.34
% of Revenue 33.40 33.18 33.41 33.63 34.74 35.76 36.56 37.31 37.00 36.70 36.91 37.13 38.24 39.53 42.86 46.65 46.36 46.08 45.51 44.98
R&D 63 67 70 73 94 115 124 133 129 125 136 146 170 195 210 225 277 330 378 427
Change (%) 5.18 4.88 4.66 28.59 22.23 8.15 7.53 -3.01 -3.10 8.05 7.45 17.00 14.53 7.64 7.10 23.34 18.92 14.68 12.80
% of Revenue 0.96 0.96 0.95 0.95 1.17 1.38 1.44 1.49 1.43 1.37 1.47 1.56 1.97 2.44 2.80 3.21 3.83 4.42 4.94 5.43
OpEx 3,965 4,183 4,402 4,622 4,904 5,186 5,394 5,602 5,600 5,598 5,654 5,710 5,505 5,300 5,323 5,345 5,582 5,819 6,011 6,204
Change (%) 5.49 5.25 4.99 6.10 5.75 4.01 3.86 -0.04 -0.04 1.00 0.99 -3.59 -3.72 0.42 0.42 4.43 4.24 3.31 3.21
% of Revenue 60.24 60.22 60.20 60.18 61.23 62.21 62.44 62.65 61.91 61.18 61.25 61.32 63.55 66.15 70.84 76.20 77.08 77.90 78.43 78.94
Operating Income 2,617 2,763 2,911 3,059 3,105 3,151 3,245 3,340 3,446 3,552 3,578 3,603 3,158 2,713 2,191 1,669 1,660 1,650 1,653 1,656
Change (%) 5.60 5.35 5.07 1.51 1.49 2.99 2.90 3.19 3.09 0.70 0.70 -12.35 -14.09 -19.23 -23.81 -0.56 -0.57 0.16 0.16
% of Revenue 39.76 39.78 39.80 39.82 38.77 37.79 37.56 37.35 38.09 38.82 38.75 38.68 36.45 33.85 29.16 23.80 22.92 22.10 21.57 21.06
Interest Expense -35 -28 -23 -19 -24 -28 -34 -39 -44 -49 -51 -52 -49 -46 -46 -47 -43 -39 -33 -28
Change (%) -21.43 -14.68 -17.21 22.71 18.51 19.19 16.10 12.74 11.30 3.15 3.06 -5.68 -6.03 0.48 0.47 -8.65 -9.47 -13.43 -15.52
% of Revenue -0.53 -0.40 -0.32 -0.25 -0.30 -0.34 -0.39 -0.44 -0.49 -0.54 -0.55 -0.56 -0.57 -0.58 -0.62 -0.67 -0.59 -0.52 -0.44 -0.36
Net Income 2,300 2,530 2,704 2,878 2,948 3,017 3,103 3,189 3,224 3,259 3,320 3,381 2,891 2,401 1,896 1,390 1,505 1,620 1,635 1,651
Change (%) 10.00 6.88 6.44 2.41 2.36 2.84 2.76 1.10 1.09 1.88 1.84 -14.50 -16.95 -21.05 -26.66 8.25 7.62 0.95 0.94
% of Revenue 34.95 36.43 36.98 37.48 36.81 36.19 35.92 35.66 35.64 35.62 35.97 36.31 33.37 29.96 25.23 19.82 20.78 21.69 21.33 21.00

Source: Capital IQ

Other Listings
SG:8A8 SGD 2.22
US:CHSYF
HK:867 HK$ 13.65
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista